Member Info for beinthelead

Hopefully, Watching. Hopefully.

Avcata won’t be here in four and a half years.

Exactly. What a thread… add it to the list of cliches.

That’s a great point Rip. Forgot about the ODD. I bet he wouldn’t have told us. But thinks submitting an application for CE marking is material…

Anyway, off the high horse. Is it summer yet?? Where’s that inflection point. Aluuuuuun!!!

https://www.fiercebiotech.com/biotech/takedas-4b-drug-clears-psoriasis-one-third-patients-laying-down-marker-bid-challenge-bms

Eggy is back out after a fortnight in the cold. The rest will follow shortly. Stand by your beds.

Jackester - that’s the point, we don’t know what’s changed.

Improve communications. Quite simple.

P1ssed off*

Exactly.

It’s no wonder people get sick here and move on. The Launch purchase, great stuff. What’s it mean? Are selling aff powered products? When?

Me biggest concern is they larger holders get P1a sec and move on. That’s when sentiment really starts impacting. The fact they’re still here speak volumes (science is far better than the company).

I’m crossing everything for a buy out sooner rather than later.

Including and mandating biopsies in the control arm trial are mega bullish. They could have implied efficacy like others do. But they chose to go this route… great to see.

What’s not so great is the conclusions we must jump to in ASs black out. We had a colourful slide delivering strategy and timelines before the trial. Hence my money being wired across. Nothing since.

He needs to put and end to speculation. At least on the main stuff. The work done here by RAH et al is brilliant. AS; far less so.

Certainly.

Communication is abhorrent. Not the entire reason we’re down, but will prevent more money flooding in when the market decides to be less fickle.

Miton et al. Must be spitting feathers with him.

Buys showing as sells. Too good not to buy. Can’t get a quote to buy. Cheapest it’s ever been. No safe place for your cash. This is a gift.

Insert whichever cliche you like.

Rip summed it up. AIM is 54ite. The minute I leave this market, with or without Avacta the better.

Don’t say that Timster. They’ll be after you. I feel like the guy off the scotch tapes advert.

He’s certainly sneaky Timster. More posts to report.

Praise be.

AS? Wonder what he’s on with.

Because you can’t rush a clinical trial. They’re there for a reason.

Can’t believe our luck.

My eggs are now firmly in this basket. A market where we’ve had to rely on Google translate to keep us update. Key updates include;

New office furniture.
Shiny PDF where they’re gonna do stuff in 2030.

Forget AVA6000. It’s all about the Affimer. The market can’t get enough. Huge value attributed. Large trades expected.

AS is very clear that his Vision is about improving patient outcomes. He states, with passion, that all people should have access to life changing medication. Rest assured AVA6000 won’t be out of reach financially.

I don’t think Avacta will get AVA6000 to market. Somebody else will. It will then replace dox as SoC. Dox is a palliative drug for STS. Let’s see if that can be changed.

Hurst is more annoying than Ndn ever was. Henrik whatever his face is a full on loon.